Severe community-acquired pneumonia (CAP) and the Infectious Diseases Society of America/American Thoracic Society CAP guidelines prediction rule: Validated or not

Clinical Infectious Diseases

Volumn 48, Issue 4, 2009, Pages 386-388

  Mandell, Lionel A ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL VENTILATION; COMMUNITY ACQUIRED PNEUMONIA; DISEASE SEVERITY; ENDOTRACHEAL INTUBATION; HUMAN; INTENSIVE CARE UNIT; MEDICAL SOCIETY; MORTALITY; NOTE; PATIENT TRANSPORT; PRACTICE GUIDELINE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEPTIC SHOCK; VALIDATION PROCESS;

COMMUNITY-ACQUIRED INFECTIONS; CRITICAL ILLNESS; HOSPITALIZATION; HUMANS; PNEUMONIA; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 58749096510     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/596308     Document Type: Note

References (12)

1. Leroy O, Santre C, Beuscart C, et al. A five-year old study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Intensive Care Med 1995; 21:24-31.
2. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999; 115:462-74.
3. Niederman MS, Bass JB, Campbell GD, et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis 1993; 148:1418-26.
4. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163:1730-54.
5. British Thoracic Society Research Committee. Community-acquired pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors, and outcome. Q J Med 1987; 62:195-220.
6. Lim WS, van der Eerden MM, Laing R, et al. Defining community-acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58:377-82.
7. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336:243-50.
8. Ewig S, Ruiz M, Mensa J, et al. Severe community-acquired pneumonia: assessment of severity criteria. Am J Respir Crit Care Med 1998; 158:1102-8.
9. Angus DC, Marrie TJ, Obrosky DS, et al. Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic Criteria. Am J Respir Crit Care Med 2002; 166:717-23.
10. Ewig S, de Roux A, Bauer T, et al. Validation of predictive rules and indices of severity for community-acquired pneumonia. Thorax 2004; 59:421-7.
11. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007;44:S27-72.
12. Liapikou A, Ferrer M, Polverino E, et al. Severe community-acquired pneumonia: validation of the Infectious Diseases Society of America/American Thoracic Society Guidelines to predict an intensive care unit admission. Clin Infect Dis 2009; 48:377-85 (in this issue).